Novo Nordisk sues Hims & Hers over ‘knock-off Wegovy’

Pharmaceutical elephantine Novo Nordisk announced Monday it is suing telemedicine level Hims & Hers for allegedly “deceiving patients and putting their wellness astatine risk” by selling compounded versions of its blockbuster GLP-1 medicine semaglutide. Novo Nordisk alleges successful its suit that Hims & Hers has infringed connected its patent by selling compounded Ozempic and Wegovy…